Vitrolife AB Mutual Funds

Health Care & Life Sciences » Biotechnology | Vitrolife AB

Vitrolife AB | Mutual Funds

Mutual Funds that own Vitrolife AB

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

American Funds Small Cap World Fund

5,002,795

4.61%

168,000

0.19%

06/30/2018

Lannebo Småbolag

2,500,000

2.29%

125,000

1.21%

12/31/2017

Government Pension Fund - Global (The)

2,170,425

1,199,795

12/31/2017

Morgan Stanley Instl. Fund-International Opportunity Port.

1,575,285

1.45%

561,050

1.91%

06/30/2018

GLG International ICVC - Esprit Continental Europe Fund

1,191,055

1.1%

0.78%

07/31/2018

Echiquier Agenor

965,000

0.89%

290,000

1.73%

03/29/2018

Fjarde AP Fonden

930,100

0.86%

930,100

0.03%

12/31/2016

Echiquier Entrepreneurs

880,715

0.81%

880,715

2.66%

06/30/2017

Vanguard Total International Stock Index Fund

865,255

0.8%

07/31/2018

Allianz Global Investors Fund - Europe Small Cap Equity

788,870

0.73%

-24,050

1.37%

05/31/2018

About Vitrolife AB

View Profile

Address	Gustaf Werners Gata 2 Gothenburg VG 421 32 Sweden
Employees	-
Website	http://www.vitrolife.com
Updated	07/08/2019
Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. It operates through the following geographical segments: EMEA, North and South America, and Asia & Pacific. Its products include FertiRoof, Vitrification, Slow freezing, OVOIL-culture oil, and Follicle aspiration needles.